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Considerable controversy surrounds the issue of
whether to use a shunt during carotid endarterecto-
my (CEA).1-5 Even among those surgeons who
believe in shunting, debate continues on whether to
shunt routinely or selectively2,3,6,7 and on which
shunt to use.8 There are two main types of shunt:
some (eg, the Javid) have a greater mean luminal
diameter but are relatively stiff and inflexible; others
(eg, the Pruitt-Inahara) have a smaller proximal
lumen but are generally more flexible. The large-
diameter shunts have been criticized because it is not
always possible to insert them into the distal end of
the internal carotid artery (ICA), given the small
diameter of that vessel.3 There are also occasional
reports of these large-diameter shunts damaging ves-
sel endothelium,9 the result being embolism or even
thrombosis.10,11
The smaller shunts have been criticized on the
basis of their smaller luminal diameter and, because
flow is inversely proportional to the fourth power of
the radius, their greater resistance to blood flow.8,12
A study of 163 patients found that the Javid shunt
failed to maintain preoperative middle cerebral
artery velocities (MCAVs) in 41%; the correspond-
ing figure for the Pruitt-Inahara device was 66%.8
The present study was performed to examine MCAV
changes in 548 patients who were routinely shunted
with the Pruitt-Inahara shunt, examining not only
the deviation from preoperative flow rates but also
the relation between use of the shunt and markers of
inadequate perfusion.
The Pruitt-Inahara shunt maintains mean
middle cerebral artery velocities within
10% of preoperative values during carotid
endarterectomy
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Objective: The purpose of this study was to assess the ability of the Pruitt-Inahara shunt
to maintain adequate middle cerebral artery velocities during carotid endarterectomy.
Study design: Prospectively collected data recorded during 548 carotid endarterectomies
performed at a single university hospital were analyzed to look at changes in cerebral
blood flow velocities at different stages during the procedure. Parallel data relating to
blood pressure and end-tidal carbon dioxide were also examined.
Results: During the first carotid artery cross clamp, middle cerebral artery velocity fell
by 42%. A total of 169 patients (31%) had velocities that fell below 15 cm/s (electrical
activity in the brain becomes altered below this level). After shunt insertion, only 2% of
patients had middle cerebral artery velocities less than 15 cm/s. In only one patient was
the velocity less than 10 cm/s. Increased systolic or diastolic blood pressure raised flow
through the shunt significantly (P = .001). When two criteria used for selective shunt
use were compared, only a moderate correlation was found between absolute middle
cerebral artery velocity after carotid cross clamping and percentage change in middle
cerebral artery velocity relative to preclamp values.
Conclusions: The Pruitt-Inahara shunt is able to maintain adequate middle cerebral
artery velocity in 98% of patients undergoing carotid endarterectomy. Alterations in
blood pressure can significantly affect flow through the shunt. (J Vasc Surg 2000;
32:299-306.)
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PATIENTS AND METHODS
CEA was performed in a standardized manner
throughout the study period (September 1992
through September 1998). This is not a consecutive
series, inasmuch as transcranial Doppler scan moni-
toring was not possible between October 1994 and
October 1995 because of staffing levels. Data are
presented for the 548 patients undergoing CEA in
whom intraoperative transcranial Doppler (TCD)
monitoring was possible. In no case did a patient
undergo a bilateral CEA at a single operation.
During the period in which intraoperative TCD
monitoring was performed, there were 56 patients
for whom no data were available. In 44 patients
there was an inadequate temporal window. In three
cases the wrong artery was insonnated (usually this
was the posterior cerebral artery), and in seven cases
the quality of the recorded data did not allow for
accurate analysis.
The operation was undertaken with the patient
under normocarbic, normotensive general anesthe-
sia through use of systemic heparinization. A Pruitt-
Inahara shunt (Horizon Medical, Santa Ana, Calif)
was used in all cases. The ICA and the common
carotid artery (CCA) were temporarily clamped, and
a short arteriotomy was performed. The distal end
of the shunt was inserted into the CCA, and 0.75 to
1.25 mL of saline solution was used to gently inflate
the proximal balloon. The shunt was then flushed
through with blood from the CCA. The distal shunt
was inserted into the ICA, the balloon inflated, and
the shunt opened. The proximal balloon was gently
held with a rubber sling to prevent dislodgement.
The arteriotomy was then extended to the appropri-
ate length and the endarterectomy performed. The
proximal and distal intimal steps were tacked down
with 7-0 Prolene (Ethicon, Inc, Somerville, NJ) and
each arteriotomy was closed with a patch angioplas-
ty. Completion angioscopy was performed in each
case after removal of the shunt. Detection of
retained luminal thrombus or an intimal flap (> 3
mm) was noted. Patients were reshunted for the cor-
rection of technical defects.
Intraoperative TCD monitoring of the MCAV
was performed by means of a 2-MHz fixed-head
probe (SciMed UK Ltd, United Kingdom). The
mean MCAV was calculated automatically by the
software accompanying the TCD package. The cal-
culation is based on integration of the velocity wave-
form over several cardiac cycles with a Fast Fourier
transform (this approximates closely to the following
formula: mean MCAV = diastolic MCAV + [systolic
MCAV – diastolic MCAV)/3]). The MCAV and sys-
tolic and diastolic blood pressures were prospective-
ly recorded for all patients at the following time
points:
1. during dissection before the first ICA clamping
2. after the first ICA clamping
3. after shunt insertion and restoration of flow
4. after the second ICA clamping
5. after shunt removal and restoration of flow
through the endarterectomized vessel.
All of the data were collected in the appropriate
minute before or after each clamping or flow release.
The MCAVs were recorded at the same time that 
the blood pressure and end-tidal carbon dioxide
(ETCO2) were recorded. Subsequent data analysis
was performed blinded to patient outcome. The
groups of data relating to changes in MCAV were
compared with one another through use of the t test
or the χ2 test, as appropriate.
Previous work has defined an MCAV of 15 cm/s
as the point below which the cerebral perfusion is no
longer adequate to maintain electric activity.13 When
the MCAV falls to less than 10 cm/s, the perfusion is
inadequate to maintain the basic metabolic needs of
the cerebral tissue. Other studies have defined a fall in
MCAV of greater than 50% to 70% as a critical point
in cerebral perfusion.14,15 Falls of 50% and 60% have
been compared with one another in this study.
After October 1995, all patients were monitored
for 3 to 6 hours postoperatively by means of the TCD
device. Patients who exhibit either significant num-
bers of particulate emboli (> 25 in a 10-minute peri-
od) or distortion of the waveform in the middle cere-
bral artery are at risk of complete occlusion of the
carotid artery.16,17 These patients were treated with
10% dextran-40, beginning at a rate of 20 mL/h. If
the number of emboli failed to decline, the rate of the
dextran-40 infusion was increased by 5 mL/h every
10 minutes to a maximum rate of 40 mL/h. Once the
rate of embolization had stabilized, the dextran-40
therapy was continued for 12 hours. Our unit proto-
col was that if the maximum dose of dextran-40 failed
to control the embolization, the patient was to be
reexplored; however, all cases of sustained emboliza-
tion settled with the use of dextran-40.
Any new neurologic deficit lasting longer than
24 hours was classified as a stroke. Each patient was
assessed by means of computed tomography head
scanning, carotid duplex scanning, and further TCD
monitoring, with or without a return to the operat-
ing room for further exploration. The severity of the
stroke was determined by a neurologist using the
Oxford Handicap Scoring system.18
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RESULTS
All patients in the study were shunted through
use of a Pruitt-Inahara looped outlying shunt. In 17
patients (3.1%), the shunt required physical manip-
ulation after initial insertion. The surgeon perform-
ing the operation was alerted to the need for shunt
adjustment by changes in the MCAV monitored
with the TCD device. A common cause of poor ini-
tial MCAV was overinflation of the distal balloon
within the ICA; another was impaction of the shunt
lumen on a distal kink or loop, occluding shunt out-
flow. Movement of the shunt during the operation
occasionally impaired flow, and again this was
quickly detected by a fall in the MCAV detected
with the TCD device, allowing corrective action to
be taken.
There were no strokes or deaths directly attrib-
utable to shunt use in this series of patients. The
morbidity and mortality figures are shown in Table
I. The mortality rate was 1.3%. The disabling
stroke rate was 0.9%, and the nondisabling stroke
rate was 1.3%. Each of the 2 on-table thromboses
was reopened before the patient left the operating
room, and thrombus was found within the
endarterectomy zone in the absence of technical
error. Before implementation of our policy of post-
operative monitoring and selective dextran-40
therapy, there were four postoperative carotid
thromboses, and on reexploration, thrombus was
found adherent to the endarterectomized vessel.
Two patients had sustained embolization, which
was prevented from proceeding to thrombosis by
the use of dextran-40 therapy. There were 3
patients in whom no cause for the postoperative
stroke could be identified, despite the use of
carotid duplex scanning, further TCD monitoring,
reexploration, and computed tomography head
scanning. In none of these patients was a thrombus
or intimal flap identified outside the endarterecto-
my zone that could have been responsible for the
stroke. None of these three patients awoke with a
neurologic deficit, and their strokes occurred in the
postoperative period. Thus, embolization through
the shunt during surgery was not the cause of these
deficits. In addition, each of the three patients had
an MCAV greater than 25 cm/s with the shunt in
place, making hypoperfusion a very unlikely source
of the neurologic deficit.
Changes in MCAV during CEA. Table II sum-
marizes the changes that take place in MCAV during
five separate stages of CEA. In the pre-ICA clamp-
ing, or dissection, phase, only four patients (1%) had
MCAVs below 15 cm/s and none had an MCAV
below 10 cm/s. After clamping of the ICA for the
first time, the MCAV fell below the critical 15 cm/s
level in 169 patients (31%). With placement of a
flexible looped Pruitt-Inahara shunt, the MCAV
rose to above 15 cm/s in 159 (94%) of these
patients. One patient’s MCAV remained at 9.7 cm/s
for 1 minute after shunt insertion. This was partially
due to a low systolic blood pressure (SBP), and the
MCAV rose above 10 cm/s when the anesthetist
pharmacologically corrected the blood pressure. Of
the 10 patients whose MCAVs remained below 15
cm/s, none had a neurologic deficit on waking from
anesthesia.
The mean MCAVs during the five stages of the
CEA are shown in Table III. There are significant
falls in MCAV after both ICA clampings relative to
the preclamp values (P < .001). The average fall in
velocity was 42% after the first clamping and 38%
after the second clamping. During shunting, veloc-
ities fell only 10% relative to preclamping values,
from 39.5 cm/s to 34.2 cm/s. There was a signifi-
cant correlation between the MCAV before clamp-
ing and the MCAV seen with the shunt open (R =
0.68; P < .01). The MCAV showed a high degree of
correlation (R = 0.89; P < .005) between the first
and second clampings. There were significantly
more MCAVs less than 10 cm/s after the first
clamping than after the second (97 vs 79; χ2 =
108.2; P = .01).
The mean velocity of 50 cm/s seen in the MCA
after clamp release is significantly greater (33% average
increase; P < .001) than the preclamp values. Patients
with no flow in their MCAs during the first (46
patients) or second (34 patients) ICA clamping had a
significantly greater percentage increase in MCAV on
clamp release than was seen in patients with measur-
able MCAV on clamping (50% vs 33%; P < .05).
JOURNAL OF VASCULAR SURGERY
Volume 32, Number 2 Hayes et al 301
Table I. Morbidity and mortality in 548 patients
undergoing CEA
No. of events
Intraoperative events
On-table carotid thrombosis 2
Postoperative events
Vein patch rupture 2
Intracranial hemorrhage 2
MI or cardiac failure 3
Hyperperfusion syndrome 1
Carotid thrombosis 4
Stroke caused by sustained embolization 2
Impossible to identify cause 3
The MCAV data were studied to determine
whether there was a relationship between MCAV
and CO2, a known vasodilator. There was no signif-
icant difference between patients with low MCAVs
and patients with high MCAVs during shunting and
ETCO2. The correlation coefficient between MCAV
and ETCO2 was 0.09 during dissection, 0.19 during
clamping, and 0.14 with the shunt in situ. The
ETCO2 did not vary significantly between the vari-
ous stages of the CEA (4.3% during dissection and
4.4% with the shunt open; P = .84).
Changes in blood pressure during CEA. The
changes in SBP during CEA are shown in Table IV.
The average SBP was significantly (P < .005) elevat-
ed during clamping, shunting, and ICA release rela-
tive to pre-ICA clamp levels. These changes in SBP
are mirrored by changes in diastolic and mean blood
pressure (data not shown). In the 176 patients in
whom SBP fell between the first ICA clamping and
the second, there was an average fall in MCAV of 2.5
cm/s. In the patients who had a rise in SBP between
clampings, there was a significant increase in average
MCAV of 15.2 cm/s (P < .001). There was no cor-
relation with ETCO2 and blood pressure changes
during the operation.
The data were examined to determine whether
those patients who had low MCAVs when their
ICAs were clamped also had low blood pressures to
account for their low velocities. Those patients who
had MCAVs less than 15 cm/s had a mean SBP of
130 mm Hg; this compared with a mean SBP of 128
mm Hg for patients with higher MCAVs (P = .3).
The data were similarly examined during shunting.
In each of 10 patients, the MCAV was below 15
cm/s after the shunt had been open for 1 minute.
The mean systolic pressure in this group was
unchanged in comparison with that for the patients
with higher MCAVs (137 vs 133; P = .52). Similar
negative results were obtained when diastolic and
mean blood pressures were examined.
Analysis of data with respect to selective
shunting. Throughout this study, a policy of routine
shunt use in all CEAs was adhered to. Many units,
however, used a policy of selective shunt use, and the
study data have been analyzed accordingly. The suit-
ability of using pre–ICA clamp MCAV values to pre-
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Table II. Numbers of patients with different ranges of MCAV for five phases of CEA
No. of patients (%)
MCAV (cm/s) Preclamping First ICA clamp During shunting Second ICA clamp Flow restoration
< 10 0 (0) 97 (18) 1 (0) 79 (15) 0 (0)
10.1-15 4 (1) 72(13) 9 (2) 67 (13) 2 (0)
15.1-20 17 (3) 83 (15) 47 (9) 75 (14) 9 (2)
20.1-30 128 (23) 159 (29) 169 (31) 154 (29) 53 (10)
30.1-40 187 (34) 83 (15) 177 (32) 96 (18) 122 (23)
40.1-80 201 (37) 42 (8) 145 (26) 60 (11) 309 (58)
80+ 11 (2) 1(0) 0 (0) 0 (0) 36 (7)
Totals 548 (100) 537 (99) 548 (100) 531 (100) 531 (100)
Table III. Mean MCAV during five stages of CEA and percentage changes relative to preclamp values
Preclamp First clamp Shunt open Second clamp ICA release
Mean MCAV (cm/s) 39.5 22.1 34.2 23.7 50
± SD 14.9 13.7 12.5 13.5 18.3
Percent fall relative to — –41.8 –10.1 –37.5 32.9
preclamp values
Table IV. Relative increases in blood pressure during five stages of CEA relative to preclamp values
Preclamp First clamp Shunt open Second clamp ICA release
Mean SBP (mm Hg) 124 129 133 139 129
± SD 22.9 23.8 21.2 24.1 20.1
Percent change relative to — 6.4 9.8 14.9 6.8
preclamp values
P value — < .005 < .001 < .001 < .005
dict which patients would have low flows after ICA
clamping was assessed. Patients with MCAVs of 0
after ICA clamping were found throughout the full
range of preclamping MCAV values. There were two
patients with high preclamp MCAVs (89 and 94
cm/s) whose MCAVs fell to 0 on ICA clamping. At
only 0.16, the R2 correlation coefficient between
preclamp and postclamp (first and second) MCAV
values was not significant.
On the basis of TCD monitoring of the MCAV,
two types of criteria have been specified as indicat-
ing which patients should be selectively shunt-
ed.19,20 These are (1) a specified drop (of either
50% or 60%) in MCAV after ICA clamping and (2)
a fall in the actual MCAV after clamping to a veloc-
ity below 15 cm/s. Comparison of the patients’
actual MCAVs after ICA clamping against the per-
centage change with clamping shows a significant
correlation (R2 = 0.58; P < .001) between these
groups. However, closer examination of the data
reveals that there are a number of patients who
would require shunting by one definition of inade-
quate flow but not by the other. These data are pre-
sented in Tables V and VI. Table VII gives the sen-
sitivities, specificities, and predictive values of using
50% and 60% falls in MCAV as indicators for selec-
tive shunting. 
DISCUSSION
In this series of 548 patients, in whom data relat-
ing to shunt usage and intraoperative shunt flows were
collected prospectively, there were no strokes directly
related to shunt use. There were two on-table throm-
boses and four postoperative thromboses in the series.
One objection raised against shunt usage is that
strokes can arise as a result of damage caused by the
shunt to the endothelium in the lumen of the distal or
proximal vessel. However, consideration of the point
makes this unlikely. If the shunt does cause some
minor damage to the endothelial lining, the throm-
botic potential of the area is massively outweighed by
the 5 or 6 cm of endarterectomized vessel in which the
entire subendothelium is exposed. Indeed, in each of
our two on-table thromboses, exploration of the ves-
sel revealed thrombus attached to the endarterectomy
zone and not in the normal vessel. Before the intro-
duction of the postoperative TCD monitoring and
selective dextran-40 therapy, there were four sympto-
matic carotid thromboses, and these were reexplored;
in each case, platelet-rich thrombus was found adher-
ent to the endarterectomy zone and not within an area
of the vessel damaged by the use of the shunt. 
Insertion of the looped, outlying Pruitt-Inahara
shunt was possible in all patients. The concomitant
use of intraoperative TCD monitoring of the MCAV
was useful on a number of occasions when it identi-
fied patients in whom the shunt had been dislodged
from its original position and required adjustment.
In patients in whom only low MCAVs were obtained
after shunt opening, the TCD device was able to
detect an improvement in flow if the distal shunt
balloon had been overinflated and was then partially
deflated. TCD monitoring also allowed the blood
pressure to be manipulated to adjust flow through
the shunt. In one patient the initial MCAV after
shunt opening remained below 10 cm/s; after anes-
thetic intervention to raise the blood pressure, the
MCAV rose above the critical 10 cm/s. The use of
intraoperative TCD monitoring is a useful adjunct to
routine shunt use.
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Table VII. Predictive power of using either 50% or
60% fall in MCAV to predict need for shunt insertion
Percent fall in MCAV 
indicating need to insert shunt
> 50% > 60%
Sensitivity 85.6 78.1
Specificity 81.4 91.9
Positive predictive value 65.8 78.2
Negative predictive value 93.1 90.6
Table V. Comparison of absolute change in MCAV
against percent change in MCAV
No. of patients
MCAV > 15 cm/s MCAV < 15 cm/s
<50% fall in MCAV 311 23
>50% fall in MCAV 71 137
Boldface indicates that these patients would have been shunted
only through use of one criterion or the other.
Table VI. Comparison of absolute change in
MCAV against percent change in more than 60%
fall in MCAV after ICA clamping as indicator of
need for shunting
No. of patients
MCAV > 15 cm/s MCAV < 15 cm/s
< 60% fall in MCAV 124 39
> 60% fall in MCAV 31 121
Boldface indicates that these patients would have been shunted
only through use of one criterion or the other.
Fifteen centimeters per second has previously
been identified as velocity below which normal elec-
tric activity in the brain is replaced by abnormal
focal bursts of activity.13 Below a velocity of 10
cm/s, blood flow is inadequate for the metabolic
demands of the brain tissue. In this study, 169
patients (31%) had MCAVs below 15 cm/s after
their ICAs were clamped for the first time, and 97
patients (18%) had flows below 10 cm/s. These
results are in keeping with those of Sundt et al,21
who believed that without shunting approximately
30% of patients would be at risk of cerebral
ischemia. However, it is unlikely that all of these
patients were at risk of developing ischemic stroke,
inasmuch as a number of centers have reported
series of patients with contralateral stenosis in
whom no shunt was used and the incidence of peri-
operative stroke was acceptable.4,5 Studies using
local anesthetic and response to clamping have
found that approximately 10% of patients have a
deficit requiring subsequent shunting.7,19
There are data demonstrating that reduction of
cerebral perfusion below a critical level in some
patients does place them at risk for developing intra-
operative ischemic stroke.3,13-15,21-23 At present, it is
not possible to predict with 100% sensitivity and
specificity which patients will have ischemic stroke if
not shunted, so it would seem prudent to maintain
patients’ MCAVs as close to normal as possible dur-
ing the procedure. Although complications from the
failure of cerebral perfusion may be relatively
uncommon, the consequences can be severe.
The data in Table II demonstrate that flows
were restored above the critical limit of 10 cm/s by
insertion of the Pruitt-Inahara shunt in all but one
patient, who required blood pressure intervention.
In only 2% of patients did the shunt fail to raise the
MCAV above the level of 15 cm/s. After the first
clamping of the ICA, the mean MCAV fell by
41.8% in comparison with preclamp values. This
reduction in mean MCAV was reduced fourfold by
the opening of the shunt. With the shunt open, the
mean MCAVs were only 10.1% lower than the
preclamp values; 98% of them were within the nor-
mal range.
A recent article criticized the Pruitt-Inahara
shunt on the basis of its hemodynamic perfor-
mance.8 That study found that only 34% of patients
had their MCAVs returned to preclamp levels after
opening of the Pruitt-Inahara shunt; this compared
with 59% of those with the Javid shunt. The fact that
in the present study 98% of patients had MCAVs
within the normal range is probably more important
than the number of patients whose MCAVs actually
returned to their preclamp levels. The average fall in
MCAV of 10.1% in comparison with preclamp values
is probably of much less importance.
The MCAVs during the second period of ICA
clamping were significantly better than those during
the first clamping. A total of 97 patients had MCAVs
below 10 cm/s after the first ICA clamping; this
compared with 79 patients after the second ICA
clamping (χ2 = 108.2; P = .01). This is almost cer-
tainly due to an increase in the SBP between the two
times (Table IV) rather than to any preconditioning
induced by the first period of ischemia.
There is a significant rise in MCAV between
preclamp values and those seen in the clamp release
period. This may represent failure of cerebral
autoregulation, in which the cerebral vasculature has
been maximally vasodilated for a chronic period of
time to facilitate the suboptimal levels of flow that
may be experienced with severe carotid disease.
Interestingly, the patients who exhibited the greatest
increase in MCAV between preclamp and release
were those who had no crossover flow on clamping
of the ICA during the procedure. This confirms the
findings of a smaller previous study.20
The question of whether shunt flow can be
altered by changes in blood pressure was also exam-
ined, because this may have implications for those
patients in whom adequate shunt flows cannot be
obtained by the insertion of a shunt alone. Blood
pressure was able to influence the shunt flow. In
those patients in whom the SBP fell between the first
and second ICA clampings, there was a mean reduc-
tion in MCAV of 2.5 cm/s. In those patients whose
SBP rose between the time of the first clamping and
the time of the second, there was a mean increase in
MCAV of 15.2 cm/s (P < .001). For those centers
that shunt but do not use TCD devices to monitor
MCAV, these data indicate that maintenance of an
adequate blood pressure by the anesthetist may help
to maintain adequate shunt flows. Blood pressure is
not wholly responsible for maintaining shunt flow,
however. Those patients who had the lowest MCAVs
(< 15 cm/s) during clamping or shunting had the
same SBP as the rest of the group. Similar results
were obtained with diastolic and mean blood 
pressures as well.
All of the patients in our series were routinely
shunted. However, some centers shunt patients on a
selective basis. The data were examined to determine
whether there was a good correlation between two
different methods of determining the need for inser-
tion of a shunt: either an absolute reduction in
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MCAV after ICA clamping below 15 cm/s or the
reduction of MCAV by a given percentage relative to
preclamp levels (either 50% or 60%). Examination of
the data suggests that there is only a moderate corre-
lation between these two methods (R = 0.395).
Closer inspection of the data indicates that although
there is a good overall correlation between the two
methods, there is relatively poor discrimination in
those patients whose values approach the cutoff
points for shunting or no shunting. That is to say,
there are many patients with MCAVs around the
absolute value of 15 cm/s, but these are equally dis-
persed on either side of the relative decrease in
MCAV of 50%. 
The negative and positive predictive values of
50% and 60% falls in MCAV as indicators for shunt
insertion are shown in Table VII. Although the
specificity of the 60% cutoff point is good at 91.9%,
its sensitivity is relatively poor at 78.1%. In selecting
patients who are at risk of cerebral ischemia during
CEA, sensitivity is more important than specificity. If
a fall of the MCAV to below 15 cm/s were taken as
a true indicator of need for shunt use, then to
achieve a sensitivity of 100% using relative fall in
MCAV as an indicator for shunting, all of the 447
patients (81.6%) with falls of more than 12.8%
would have to be shunted. If the situation were
reversed and a 50% fall in MCAV were taken as the
true indicator for shunt insertion, then all of the 487
patients (88.9%) with MCAVs less than 37.6 cm/s
would have to be shunted to achieve 100% sensitiv-
ity. With such a large percentage of patients needing
to be shunted to maintain a 100% sensitivity, it
would appear logical to routinely shunt all patients
and stop worrying about the criteria for selective
shunting. The use of routine shunt insertion allows
the surgeon to develop a routine for these proce-
dures and breeds familiarity with the technique in
the operating room staff.
The data presented here indicate that routine use
of the Pruitt-Inahara shunt allows the maintenance
of adequate MCAV during shunting in 98% of
patients. There are a small proportion of patients in
whom the shunt cannot maintain adequate flow; it
may be that modification of the shunt design 
will enable surgeons to overcome this problem.
Manipulation of blood pressure can influence
MCAV with the shunt in position. There is only
moderate agreement between the two criteria used
for selective shunting. Most important, in the 548
patients in this study who were routinely shunted,
no strokes occurred that were attributable to the use
of a shunt.
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LIFELINE FOUNDATION
E. J. Wylie Traveling Fellowship 
Guidelines: The primary purpose of the E. J. Wylie Traveling Fellowship is to provide the recipient with the
opportunity to visit a number of excellent vascular surgery centers in the United States and abroad. Though brief,
these visits stimulate academic inspiration, promote international exchange, and foster development of fraternal
fellowship in vascular surgery. The achievement of these objectives will enhance the development of the fellow’s
career in vascular surgery.
This award is not intended to support specific research interests but rather to assist the fellow in a unique oppor-
tunity for travel and professional exchange within established vascular centers in this country and abroad.
Eligibility for Selection:
1. Be under age 40 at the time of the award
2. Have completed a postgraduate vascular training program or have considerable experience in vascular
surgery supplemental to surgical training
3. Be committed to an academic career in vascular surgery and have obtained an academic appointment in a
medical school or freestanding clinic devoted to excellence in medical education
4. Have a demonstrated record of success in pursuing clinical or basic science research sufficient to ensure aca-
demic excellence in his or her pursuit of a career in vascular surgery
Selection will be made without regard to the candidate’s geographic location.
Requirements for Consideration:
A candidate submitting documentation for consideration for selection must furnish an up-to-date curriculum
vitae; a list of publications, research projects, and current research support; and a list of the centers that he or she
wants to visit. Three letters of recommendation are required, including one from the division head and another
from the chairman of the department of surgery of the institution in which the candidate holds a faculty appoint-
ment. A 500-word essay describing the objectives of the candidate’s travel plans and linking these to his or her
career goals must be appended.
Report to Committee:
A report covering your experience should be prepared and forwarded to the Chairman of the Research &
Education Committee within 3 months of completion of your fellowship travel. This report should be five to
eight double-spaced typewritten pages and should summarize your activities during the fellowship. Although fac-
tual statements of activities should be included, you are encouraged to place these within an overall context of
their impact on your education and maturation. The format of the report and its content should be suitable for
consideration by the Committee for publication in the Journal of Vascular Surgery.
Financial Support:
The generosity of W. L. Gore & Associates, Inc, has allowed the establishment of this fellowship. Their gra-
ciousness ensures the noncommercial nature of the award and its continuation in years to come. The E. J. Wylie
Traveling Fellowship of the Lifeline Foundation will pay up to $12,000 for expenses of travel, research, and cler-
ical help. The fellowship monies may not be used for other purposes.
Application:
No application forms are required. A letter demonstrating interest in applying for the E. J. Wylie Traveling
Fellowship or nominating a candidate may be sent to the Chairman of the Research and Education Committee.
Details of the application should include the materials requested above. The deadline for receiving applications
is January 15. Decisions regarding the award will be mailed to the applicants by mid April.
A letter of nomination or intent should be directed to:
Chairman
Research and Education Committee
Lifeline Foundation
13 Elm Street
Manchester, MA 01944
